QuidelOrtho Corporation
QDEL
주식 순위
#9868
QuidelOrtho Corporation specializes in the creation and production of... QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems. QuidelOrtho distributes its offerings both directly to end-users and through an extensive network of distributors. These products are utilized by professionals in settings such as medical offices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening centers, and blood/donor banks, as well as for individual, non-professional, and over-the-counter applications. Founded in 1979 and based in San Diego, California, the company maintains a global footprint, including operations across North America, Europe, the Middle East, Africa, and China.
주가
$12.84
마지막 동기화: 2026-10-16
시가총액
$880.51M
변동 (1일)
-7.69%
변동 (1년)
-70.20%
국가
US
거래 QuidelOrtho Corporation (QDEL)
카테고리
Healthcare
의 시가총액 QuidelOrtho Corporation(QDEL)
시가총액: $880.51M
October 2026 기준으로 QuidelOrtho Corporation의 시가총액은 $880.51M입니다. 이는 당사 데이터에 따르면 QuidelOrtho Corporation이 세계에서 9868th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2022부터 2026까지 QuidelOrtho Corporation의 시가총액 기록
